Clinical Trial Update: Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of different sirolimus concentrations for Kaposiform Hemangioendothelioma has completed. The study ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: West China Hospital | Conditions: Kaposiform Hemangioendothelioma | Phase 2 | Status: COMPLETED